Main menu

Identification of viral contamination of a biopharmaceutical product using nanopore sequencing


Contamination events in cell culture-derived biopharmaceuticals are very rare due to the implementation of strict testing procedures for the characterization of cell banks. However, they occurred regularly over the last decades and some of the more famous events included the detection of porcine circovirus in a rotavirus vaccine and simian virus 40 found in a poliovirus vaccine. This talk will describe the detection of contamination in a cell culture-derived biopharmaceutical observed at ViruSure. This contamination event was discovered using a cell-based in vitro adventitious agent testing approach, which is highly sensitive for the detection of virus present in underlying samples but is unable to identify the virus. Therefore, this sample was subjected to nanopore sequencing, which, after optimization of the sample preparation protocol, led to the identification of the contaminant as the epizootic haemorrhagic disease virus.

Authors: Hans-Peter Fasching

入门指南

购买 MinION 启动包 Nanopore 商城 测序服务提供商 全球代理商

纳米孔技术

订阅 Nanopore 更新 资源库及发表刊物 什么是 Nanopore 社区

关于 Oxford Nanopore

新闻 公司历程 可持续发展 领导团队 媒体资源和联系方式 投资者 合作者 在 Oxford Nanopore 工作 职位空缺 商业信息 BSI 27001 accreditationBSI 90001 accreditationBSI mark of trust
Chinese flag